237 related articles for article (PubMed ID: 9214672)
1. Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer.
Schildkraut JM; Bastos E; Berchuck A
J Natl Cancer Inst; 1997 Jul; 89(13):932-8. PubMed ID: 9214672
[TBL] [Abstract][Full Text] [Related]
2. Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer.
Webb PM; Green A; Cummings MC; Purdie DM; Walsh MD; Chenevix-Trench G
J Natl Cancer Inst; 1998 Nov; 90(22):1729-34. PubMed ID: 9827528
[TBL] [Abstract][Full Text] [Related]
3. Re: Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer.
Risch HA
J Natl Cancer Inst; 1997 Nov; 89(22):1726-7. PubMed ID: 9390546
[No Abstract] [Full Text] [Related]
4. Lifestyle and Reproductive Factors and Ovarian Cancer Risk by p53 and MAPK Expression.
Harris HR; Rice MS; Shafrir AL; Poole EM; Gupta M; Hecht JL; Terry KL; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2018 Jan; 27(1):96-102. PubMed ID: 29133366
[No Abstract] [Full Text] [Related]
5. Risk factors for epithelial ovarian tumours of borderline malignancy.
Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
[TBL] [Abstract][Full Text] [Related]
6. Incessant ovulation, mucin 1 immunity, and risk for ovarian cancer.
Terry KL; Titus-Ernstoff L; McKolanis JR; Welch WR; Finn OJ; Cramer DW
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):30-5. PubMed ID: 17220329
[TBL] [Abstract][Full Text] [Related]
7. Lifetime number of ovulatory cycles and epithelial ovarian cancer risk in African American women.
Peres LC; Moorman PG; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy M; Cote ML; Funkhouser E; Peters ES; Schwartz AG; Terry PD; Abbott SE; Camacho F; Wang F; Schildkraut JM
Cancer Causes Control; 2017 May; 28(5):405-414. PubMed ID: 28251458
[TBL] [Abstract][Full Text] [Related]
8. Lifetime ovulatory cycles and ovarian cancer risk in 2 Italian case-control studies.
Pelucchi C; Galeone C; Talamini R; Bosetti C; Montella M; Negri E; Franceschi S; La Vecchia C
Am J Obstet Gynecol; 2007 Jan; 196(1):83.e1-7. PubMed ID: 17240246
[TBL] [Abstract][Full Text] [Related]
9. Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States).
Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Vine MF; Berchuck A
Cancer Causes Control; 2002 Nov; 13(9):807-11. PubMed ID: 12462545
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.
Kotsopoulos J; Lubinski J; Gronwald J; Cybulski C; Demsky R; Neuhausen SL; Kim-Sing C; Tung N; Friedman S; Senter L; Weitzel J; Karlan B; Moller P; Sun P; Narod SA;
Int J Cancer; 2015 Sep; 137(5):1136-46. PubMed ID: 25482078
[TBL] [Abstract][Full Text] [Related]
11. Metaplastic potential of p53 down-regulation in ovarian surface epithelial cells affected by ovulation.
Murdoch WJ
Cancer Lett; 2003 Feb; 191(1):75-81. PubMed ID: 12609712
[TBL] [Abstract][Full Text] [Related]
12. Relationship between PIWIL1 gene polymorphisms and epithelial ovarian cancer susceptibility among southern Chinese woman: a three-center case-control study.
Liu S; Yan Y; Cui Z; Feng H; Zhong F; Liu Z; Li Y; Ou X; Li W
BMC Cancer; 2023 Nov; 23(1):1149. PubMed ID: 38012622
[TBL] [Abstract][Full Text] [Related]
13. Potential impact of (rs 4645878) BAX promoter -248G>A and (rs 1042522) TP53 72Arg>pro polymorphisms on epithelial ovarian cancer patients.
Dholariya S; Mir R; Zuberi M; Yadav P; Gandhi G; Khurana N; Saxena A; Ray PC
Clin Transl Oncol; 2016 Jan; 18(1):73-81. PubMed ID: 26209050
[TBL] [Abstract][Full Text] [Related]
14. Mutation and overexpression of p53 in early-stage epithelial ovarian cancer.
Kohler MF; Kerns BJ; Humphrey PA; Marks JR; Bast RC; Berchuck A
Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):643-50. PubMed ID: 8469448
[TBL] [Abstract][Full Text] [Related]
15. The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3).
Trabert B; Tworoger SS; O'Brien KM; Townsend MK; Fortner RT; Iversen ES; Hartge P; White E; Amiano P; Arslan AA; Bernstein L; Brinton LA; Buring JE; Dossus L; Fraser GE; Gaudet MM; Giles GG; Gram IT; Harris HR; Bolton JH; Idahl A; Jones ME; Kaaks R; Kirsh VA; Knutsen SF; Kvaskoff M; Lacey JV; Lee IM; Milne RL; Onland-Moret NC; Overvad K; Patel AV; Peters U; Poynter JN; Riboli E; Robien K; Rohan TE; Sandler DP; Schairer C; Schouten LJ; Setiawan VW; Swerdlow AJ; Travis RC; Trichopoulou A; van den Brandt PA; Visvanathan K; Wilkens LR; Wolk A; Zeleniuch-Jacquotte A; Wentzensen N;
Cancer Res; 2020 Mar; 80(5):1210-1218. PubMed ID: 31932455
[TBL] [Abstract][Full Text] [Related]
16. Lifetime ovulatory years and ovarian cancer gene expression profiles.
Sasamoto N; Stewart PA; Wang T; Yoder SJ; Chellappan S; Hecht JL; Fridley BL; Terry KL; Tworoger SS
J Ovarian Res; 2022 May; 15(1):59. PubMed ID: 35562768
[TBL] [Abstract][Full Text] [Related]
17. p14 expression differences in ovarian benign, borderline and malignant epithelial tumors.
Cabral VD; Cerski MR; Sa Brito IT; Kliemann LM
J Ovarian Res; 2016 Oct; 9(1):69. PubMed ID: 27770808
[TBL] [Abstract][Full Text] [Related]
18. Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup.
Schildkraut JM; Moorman PG; Bland AE; Halabi S; Calingaert B; Whitaker R; Lee PS; Elkins-Williams T; Bentley RC; Marks JR; Berchuck A
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):585-93. PubMed ID: 18349276
[TBL] [Abstract][Full Text] [Related]
19. [Expression P53 protein and chromosome aberrations in benign tumors and ovarian carcinoma].
Kamiński K; Putowski L; Oleszczuk J
Ginekol Pol; 2003 Sep; 74(9):741-5. PubMed ID: 14674118
[TBL] [Abstract][Full Text] [Related]
20. Lifetime Number of Ovulatory Cycles and Risks of Ovarian and Endometrial Cancer Among Postmenopausal Women.
Yang HP; Murphy KR; Pfeiffer RM; George N; Garcia-Closas M; Lissowska J; Brinton LA; Wentzensen N
Am J Epidemiol; 2016 May; 183(9):800-14. PubMed ID: 27190045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
